Hengeler Mueller advises Gerresheimer in relation to the acquisition of Centor
29. July 2015
Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding Inc. The purchase price amounts to USD725m on a cash free and debt free basis and will be fully debt financed. Centor is a leading manufacturer of plastic vials and closures for oral drugs in the US prescription retail market.
Hengeler Mueller advised Gerresheimer on the acquisition financing and on German capital markets law matters. The Hengeler Mueller team is led by partner Nikolaus Vieten (Finance) and includes partners Thomas O. Cron (Finance, both Frankfurt) and Matthias Blaum (Capital Markets, Düsseldorf) as well as associates Sabine Albrecht (Finance, Frankfurt) and Gerrit Forst (Capital Markets, Düsseldorf). Hengeler Mueller had just recently also advised Gerresheimer on the refinancing of its syndicated revolving credit facility.